Baird initiated coverage of Immunocore with an Outperform rating and $84 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMCR:
- Immunocore to present at upcoming investor conferences
- Immunocore presents three-year overall survival data from KIMMTRAK Phase 3 trial
- Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
- Immunocore announces upcoming presentation and posters at ESMO 2023
- Immunocore price target raised to $85 from $75 at Oppenheimer